Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.800
+0.580 (13.74%)
At close: Feb 6, 2026, 4:00 PM EST
4.750
-0.050 (-1.04%)
After-hours: Feb 6, 2026, 7:41 PM EST
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $207.72 million as of February 6, 2026. Its market cap has increased by 1,275.61% in one year.
Market Cap
207.72M
Enterprise Value
255.43M
1-Year Change
1,275.61%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $207.72M, an increase of 87.81%. That is a compound annual growth rate of 5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 33.60M | 19.57% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 197.38M |
| NeOnc Technologies Holdings | 190.56M |
| Surrozen | 190.37M |
| Ovid Therapeutics | 190.07M |
| SAB Biotherapeutics | 189.48M |
| Camp4 Therapeutics | 188.33M |
| Tonix Pharmaceuticals Holding | 187.98M |
| Galectin Therapeutics | 184.39M |